Seeking Alpha

Medminer

Medminer
Send Message
View as an RSS Feed
View Medminer's Comments BY TICKER:
Latest  |  Highest rated
  • Is Ampio Pharmaceuticals Wall Streets' Next Cinderella Stock? - Several Upcoming Announcements Will Soon Tell [View instapost]
    So once again AMPE has released great news that in most cases would send a companies stock soaring. The problem continues to be lack of buying at an institutional level. Many of the current shareholders hoped to see AMPE at $15-20/share by the end of this year. Unfortunately, this is a dream do to a clear lack of a solid investment banker that can expose AMPE to the world.

    The company is simply not on any institutional buyers radar screen. It clearly appears that the stock will continue to rock slowly back and forth until actual revenue is realized. Its really a shame, especially with the fantastic news being released. I am long, but maybe not for "long"
    Oct 8, 2013. 06:21 PM | Likes Like |Link to Comment
  • Ampio Pharmaceuticals, Inc. Announces Positive Results from Independent Panel Review of the Interim Analysis of the Optina(TM) Trial for Diabetic Macular Edema [View article]
    So once again AMPE has released great news that in most cases would send a companies stock soaring. The problem continues to be lack of buying at an institutional level. Many of the current shareholders hoped to see AMPE at $15-20/share by the end of this year. Unfortunately, this is a dream do to a clear lack of a solid investment banker. The company is simply not on any institutional buyers radar screen. It clearly appears that the stock will continue to rock slowly back and forth until actual revenue is realized. Its really a shame, especially with the fantastic news being released.
    Oct 8, 2013. 06:21 PM | Likes Like |Link to Comment
  • Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform [View article]
    Once again great news has been released with little to no movement in the share price. Is this do to the news from the last few days not being substantial enough?, NO. Is the lack of movement from the short players trying to cover themselves from the huge plays made at lower levels? NO. Is it do to the markets in general flip flopping around from world news or government issues? NO, NO, NO!!

    It is clearly obvious that the lack of movement is from lack of volume and this is from lack of information being disseminated properly. Very, very few people/organizations know or understand who and what Ampio is. Information that has been released recently would have sent most company shares up in rocket fashion.

    Why do you think we are not hearing anymore negative "Product" news from the short folks? Because the news is now consistently positive, and Ampio has turned the corner. But, the shorts are still having a field day from lack of "buying". So the big question is when will Mike Macaluso and the management team use a large investment firm to move this company forward.

    It is absolutely ridiculous that with the limited shares issued, and the fantastic product news being released, that no one knows about the company. Come on Mike!! it's time to get you head out and start managing the shareholders. If you have not figured it out yet, in your position you need to manage 3 major areas, The company, The product and Wall Street aka "The shareholders" you have done a reasonably decent job with the first 2 but have fallen completely on your face with third.

    The window of opportunity is open NOW, please understand that the uniqueness of this situation does not last forever. Or sure, eventually from sales or other deals the stock will move in accordance with standard P/E ratios. But the uniqueness of this story only happens a few times in a decade. If not pushed soon Ampio may fall into that same old ebb and flow that polished organizations/management typically avoid. Lets show the world that Ampio has a story to tell, and is not being shareholder managed by a hack.
    Oct 1, 2013. 09:34 PM | Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    WOW, your short! I would have never guessed! The only information that is new about this article coming from a short player is the date. We have all heard these ridiculous, inconsistent, half truths and wrongfully misleading statements before. I have been in the medical business since 1987 and made many,many times my investments in the industry.

    I am always amazed at the complete idiocy of investors, fund managers and individuals who made the wrong play (short), and continue to push their agenda hoping to turn the unavoidable, inevitable course and destiny of a growing solid company around to their manipulative thought process. It won't work this time, and in most cases never does for those who try at this stage with a company who has a solid pipeline. The proof will be out shortly, and you are about to take a major bath. Oh sure, Ampio has made some mistakes with their shareholders, but their INTENT has always been rock solid, especially when you evaluate their pipe vs. this multi-billion dollar industry.

    I do want to thank you for one thing though! It has allowed this stock to be a great play off the yo yo you have created. Rapid rise, get out, shorts make rapid fall, get back in, only this time buying one third more off the gains made. Please try this one or two more times before the big releases come out, I want to buy 10-15 thousand more shares and don't have the $50-75,000 needed.

    It's so easy to see, it's like taking candy from a baby. So please, one or two more times while the price is still under $10/share!!!

    By the way, I'm long except for the in and out gains from our short friends, but I bet you would have never guessed that.
    Jun 6, 2013. 09:52 PM | 6 Likes Like |Link to Comment
  • Ampio Pharmaceuticals' Pipeline Doesn't Look Good [View article]
    Adam, obviously you must have some kind of significant medical background. Maybe we should call you Dr. Adam with all of the side comments you make in your article. It appears that your knowledge base includes understanding PE well enough to comment on pleasure percentages and psychologically related traits to this very common problem. I suppose your thoughts on ED related problems are also based on psyhcologically related issues. For many years those were the very thoughts that squelched the progression of medical treatment for ED. If as you state it's all in your head, then why wouldn't one get enhanced pleasure knowing that his partner is more satisfied. You can't have it both ways!
    As far as your comments in relationship to Ampion, again you must have some former medical understanding to make a judgment call in reference to pain thresholds. I guess a 2:1 ratio of improvement would in your mind not be "statistically significant".
    Then we move on to Optina which you also "in your opinion" see as a "small improvement". Once again, moving up a whole category in improvement progression is not significant. What you don't mention is what occurs when diagnosed and treated early enough and what the drug does to slow the progression significantly. Furthermore, in many cases, this type of vision loss is related to other factors such as kidney/protein loss. Maybe patients would like to see their vision loss slowed while diagnosis and treatment to the underlying factors are being addressed.
    Lastly, the press releases you talk about as pumps are required as you are well aware of, and further, that is why the term "pipeline" is used. Investors want to understand what is down the road. Ampio does not seem to be having difficulty raising funds, so the real question is why hold back on future products as the company waits for the approval process of currently developed products.
    I'm glad there are many shorts out there. It's helping me purchase at much lower prices than I ever thought possible. Keep those shorts coming, and get ready to buy to cover. As you can imagine I'm long.
    Aug 29, 2012. 12:48 PM | Likes Like |Link to Comment
  • Traders Eye Ampio [View article]
    I am very confused! Currently, I am long on Ampio an have been very intrigued by all of the negative comments on this web site blog. I have had a high degree of respect for Adam Feuerstein's evaluations in the past, but I am perplexed by the negativity from his and other recent comments and evaluations of Ampio and what I thought were a promising opportunity of drugs. I'm trying to sort through the wheat from the chaff in order to sell or hold, please help me out here!

    As I see the facts, it would appear that Ampio has a dynamite payload of products that although it will no doubt take some time to push through, would appear to be very promising and extremely profitable. Although, the stock has recently gone up and then back down, the insiders are looked up, and with the recent capital raise the company is in good position from a capital standpoint. The fillings also appear to be open, honest, and from an FDA standpoint moving in the right direction. Some have suggested that the company is bleeding cash, but in my experience in big Pharma, the amount that they have spent and are spending is infinitesimal in comparison to what they are trying to accomplish. Further, now that the latest round has replenished the kitty it would appear that they are well funded and on there way to completion.

    The fact that one of the drugs is in a stage III trial points to conclusion in the near future with a huge upside. In the past 6 months or so there has been many back and forth comments about the small items or as I look at the situation the "trees". But what about the "forest" ? Realizing the devil is in the detail in many situations I'm confident but perplexed as to the reality of the overall long term outcome in relation to the comments.

    Facts!! I think! Good pipeline, cash in the bank, locked up insiders, and some product in late stage trials would appear to be a great buying opportunity. But, as I stated upfront "I'm confused" ?
    Jul 16, 2012. 10:49 PM | Likes Like |Link to Comment
  • Pharma's Untapped Gold Mine [View article]
    I agree with you I also have not heard of that formal request. But then again, Ampio is fighting a battle with the short players at a level that is not typical, and not this severe, this early in their short public lifespan.
    Jun 20, 2012. 01:19 AM | Likes Like |Link to Comment
COMMENTS STATS
7 Comments
6 Likes